Overview

Bevacizumab and Carboplatin for Patients With Ovarian Cancer

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This is a phase II trial to investigate the effect of bevacizumab and carboplatin in patients with platin resistant ovarian cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Vejle Hospital
Treatments:
Bevacizumab
Carboplatin